Khozema Palanpurwala
Pediatrics · Houston, TXNPI 1386611721
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 68 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Ironshore Pharmaceuticals Inc. at 25.0% of the total. Reporting peaked in 2024 at $302 and has fallen 63.3% since, to $111 in 2025.
Across 68 payments — averaging $19.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$340
- GSK$166
- Tris Pharma Inc$129
- Takeda Pharmaceuticals U.S.A., Inc.$114
- Supernus Pharmaceuticals, Inc.$110
- Corium, LLC$74
- plus $425 from 11 others
Across 576 payments — averaging $16,806 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$7.9M
- Novavax Inc$694K
- Vivus LLC$485K
- Seqirus USA Inc$209K
- AbbVie$189K
- Genentech, Inc.$80K
- plus $126K from 5 others
What the payments were for
- Food & beverage$1,358100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 17 | $340 |
| GSK | 7 | $166 |
| Tris Pharma Inc | 6 | $129 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $114 |
| Supernus Pharmaceuticals, Inc. | 6 | $110 |
| Corium, LLC | 3 | $74 |
| Merck | 4 | $63 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $61 |
| Cranial Technologies, Inc | 4 | $59 |
| Alk-abello, Inc | 4 | $57 |
| Sanofi Pasteur Inc. | 2 | $43 |
| Genentech USA, Inc. | 2 | $32 |
| Cumberland Pharmaceuticals, Inc. | 2 | $26 |
| Phadia US Inc. | 1 | $25 |
| Seqirus USA Inc | 1 | $24 |
| Circassia Inc. | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
How this compares
$1,358 in reported general payments places this provider in the 85th percentile of 5,361 pediatrics providers in Texas.
Other pediatrics in Houston
- Pedro PiedraHouston$729K
- Vernon SuttonHouston$90K
- Carlos BacinoHouston$53K
- Farida AbidHouston$50K
- Lindsay CameronHouston$32K
- Juan Torres SanchezHouston$31K
- Martin YudovichHouston$24K
- Raegan HuntHouston$23K
- Michael PickettHouston$14K
- Lara LeonhardtHouston$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.